Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR green

Molecular Genetics and Metabolism

Volumn 68, Issue 3, 1999, Pages 357-362

  Hiratsuka, Masahiro ^a   Agatsuma, Yasuyuki ^a   Mizugaki, Michinao ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Allele specific amplification; CYP2C9; Genetic polymorphism; P450; PCR; SYBR Green

Indexed keywords

CYTOCHROME P450 ISOENZYME; DOUBLE STRANDED DNA; FLUORESCENT DYE; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PLASMID DNA; RESTRICTION ENDONUCLEASE; TOLBUTAMIDE; WARFARIN;

ARTICLE; CONTROLLED STUDY; DNA TEMPLATE; FLUORESCENCE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; JAPAN; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 0032699086     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2919     Document Type: Article

References (17)

1. Guengerich F P, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol. 4:1991;391-407.
2. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich F P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 270:1994;414-423.
3. Romkes M, Faletto M B, Blaisdell J A, Raucy J L, Goldstein J A. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 30:1991;3247-3255.
4. Goldstein J A, de Morais S M. Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics. 4:1994;285-299.
5. Wang S L, Huang J, Lai M D, Tsai J J. Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese. Pharmacogenetics. 5:1995;37-42.
6. Haining R L, Hunter A P, Veronese M E, Trager W F, Rettie A E. Allelic variants of human cytochrome P450 2C9: Baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms. Arch Biochem Biophys. 333:1996;447-458.
7. Sullivan-Klose T H, Ghanayem B I, Bell D A, Zhang Z Y, Kaminsky L S, Shenfield G M, Miners J O, Birkett D J, Goldstein J A. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics. 6:1996;341-349.
8. Daly A K, Brockmoller J, Broly F, Eichelbaum M, Evans W E, Gonzalez F J, Huang J D, Idle J R, Ingelman-Sundberg M, Ishizaki T, Jacqz-Aigrain E, Meyer U A, Nebert D W, Steen V M, Wolf C R, Zanger U M. Nomenclature for human CYP2D6 alleles. Pharmacogenetics. 6:1996;193-201.
9. Rettie A E, Wienkers L C, Gonzalez F J, Trager W F, Korzekwa K R. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics. 4:1994;39-42.
10. Furuya H, Fernandez-Salguero P, Gregory W, Taber H, Steward A, Gonzalez F J, Idle J R. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy. Pharmacogenetics. 5:1995;389-392.
11. Nasu K, Kubota T, Ishizaki T. Genetic analysis of CYP2C9 polymorphism in a Japanese population. Pharmacogenetics. 7:1997;405-409.
12. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5:1989;874-879.
13. Landegren U, Kaiser R, Sanders J, Hood L. A ligase-mediated gene detection technique. Science. 241:1988;1077-1080.
14. Wittwer C T, Ririe K M, Andrew R V, David D A, Gundry R A, Balis U J. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control. Biotechniques. 22:1997;176-181.
15. Wittwer C T, Herrmann M G, Moss A A, Rasmussen R P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques. 22:1997;130-131.
16. Heid C A, Stevens J, Livak K J, Williams P M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
17. Newton C R, Graham A, Heptinstall L E, Powell S J, Summers C, Kalsheker N, Smith J C, Markham A F. Analysis of any point mutation in DNA. Nucleic Acids Res. 17:1989;2503-2516.